Nettekoven, Matthias <br/><br/>
Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases.  [electronic resource] 

 -  ChemMedChem  Jan 2016 
 - 179-89 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1860-7187 
<br/><br/><label>Standard No.: </label>10.1002/cmdc.201500218  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents, Non-Steroidal--chemical synthesis<br/>Cannabinoid Receptor Agonists--chemical synthesis<br/>Dose-Response Relationship, Drug<br/>Humans<br/>Inflammation--drug therapy<br/>Kidney Diseases--drug therapy<br/>Models, Molecular<br/>Molecular Structure<br/>Pyrimidines--chemical synthesis<br/>Receptor, Cannabinoid, CB2--agonists<br/>Structure-Activity Relationship<br/>Triazoles--chemical synthesis